Who is sponsoring NCT03066037?

NCT03066037 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT03066037?

Interventions in NCT03066037: regional-anaesthesiological infiltration.

What condition does NCT03066037 study?

NCT03066037 studies Chronic Pain, Trigeminal Neuralgia, Cluster Headache, Post-Zoster Neuralgia, Post Zoster Pain, Neuropathic Pain.

Is NCT03066037 still recruiting?

NCT03066037 is currently completed. Last updated 28 February 2017.

Last reviewed 2017-02-28 · How we verify

NCT03066037: RetroBlock

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study

Completed Last updated 28 February 2017

What this trial tests

trial testing regional-anaesthesiological infiltration in Chronic Pain in 83 participants. Completed in 13 November 2016.

Timeline

1 January 2009

Primary endpoint
30 June 2016

13 November 2016

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Status	Completed
Study type	OBSERVATIONAL
Enrollment	83
Start date	1 January 2009
Primary completion	30 June 2016
Estimated completion	13 November 2016
Sites	1 location across Germany

Drugs / interventions tested

regional-anaesthesiological infiltration

Conditions studied

Chronic Pain — all drugs for Chronic Pain →
Trigeminal Neuralgia — all drugs for Trigeminal Neuralgia →
Cluster Headache — all drugs for Cluster Headache →
Post-Zoster Neuralgia — all drugs for Post-Zoster Neuralgia →

Sponsor

Charite University, Berlin, Germany

Who can join

18 and older, any sex, with Chronic Pain or Trigeminal Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a significant debate whether local infiltration techniques may be a method to treat complicated chronic pain syndromes, e.g. refractory headache. Until now there is a lack of evidence regarding efficacy of this treatment especially in long term follow up. Similarly, indication and management are under debate. Aim of this trial is to analyse pain scores during first treatment with anaesthesiological infiltration series.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Retrospective Study on Ganglionic and Nerve Block Series as Therapeutic Option for Chronic Pain Patients with Refractory Neuropathic Pain.
Gerken JD, Fritzsche T, Denke C, Schäfer M, et al · · 2020 · cited 6× · PMID 32774567 · DOI 10.1155/2020/6042941
Supplementing transcranial direct current stimulation to local infiltration series for refractory neuropathic craniocephalic pain: A randomized controlled pilot trial.
Wandrey JD, Kastelik J, Fritzsche T, Denke C, et al · · 2023 · cited 2× · PMID 36937523 · DOI 10.3389/fneur.2023.1069434

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03066037 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 28 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03066037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing